OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
Anne Grete Semb, Eirik Ikdahl, Grunde Wibetoe, et al.
Nature Reviews Rheumatology (2020) Vol. 16, Iss. 7, pp. 361-379
Closed Access | Times Cited: 165

Showing 26-50 of 165 citing articles:

Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease‐modifying antirheumatic drugs: A multi‐centre cohort study
Xinning Tong, Chin‐Yao Shen, Ha‐Lim Jeon, et al.
Journal of Internal Medicine (2023) Vol. 294, Iss. 3, pp. 314-325
Open Access | Times Cited: 12

Effects of a telehealth-delivered Mediterranean diet intervention in adults with Rheumatoid Arthritis (MEDRA): a randomised controlled trial
Tala Raad, Elena S. George, Anne Griffin, et al.
BMC Musculoskeletal Disorders (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4

Age‐Related Trajectories of Cardiovascular Risk and Use of Aspirin and Statin Among U.S. Adults Aged 50 or Older, 2011–2018
Taeho Greg Rhee, Manish Kumar, Joseph S. Ross, et al.
Journal of the American Geriatrics Society (2021) Vol. 69, Iss. 5, pp. 1272-1282
Open Access | Times Cited: 27

Association of ceramide risk scores with rheumatoid arthritis: a FINRISK population-based cohort study
Mohammadreza Shoghli, Juha Sinisalo, A. Inkeri Lokki, et al.
BMJ Open (2025) Vol. 15, Iss. 3, pp. e090486-e090486
Open Access

From Joints to the Heart: An Integrated Perspective on Systemic Inflammation
Diana Elena Cosău, Irina Enache, Alexandru Dan Costache, et al.
Life (2025) Vol. 15, Iss. 4, pp. 629-629
Open Access

Welche Rolle spielen Adipositas und damit verbundene Stoffwechselstörungen bei der rheumatoiden Arthritis?
Wiebke Diederich, Tim Hollstein, Corinna Geisler, et al.
Arthritis und Rheuma (2025) Vol. 45, Iss. 02, pp. 110-116
Closed Access

The Prognostic and Functional Impact of Multimorbidity in Systemic Sclerosis
Jessica Fairley, Dylan Hansen, Susanna Proudman, et al.
ACR Open Rheumatology (2025) Vol. 7, Iss. 4
Open Access

Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults
Maya Safarova, Spencer F. Weintraub, Katherine Sadaniantz, et al.
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Closed Access

Evaluating the Cardiovascular Impact of Rheumatoid Arthritis through Clinical Disease Activity Index Scores: A Cross-sectional Study at a Rural Teaching Hospital
Keyur Saboo, Sunil Kumar, Sourya Acharya, et al.
Journal of the Practice of Cardiovascular Sciences (2025) Vol. 11, Iss. 1, pp. 27-34
Open Access

CXCL9 and its Receptor CXCR3, an Important Link Between Inflammation and Cardiovascular Risks in RA Patients
Afsaneh Shamsi, Seyed Askar Roghani, Zahra Abdan, et al.
Inflammation (2023) Vol. 46, Iss. 6, pp. 2374-2385
Open Access | Times Cited: 9

Prediction of Major Adverse Cardiovascular Events by Triglyceride Glucose Index in Predominantly Male Patients with Rheumatoid Arthritis
Jiawei Zhang, Qiqi Hou, Quanle Han, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 1, pp. 28-28
Open Access | Times Cited: 3

Artificial Intelligence in the Diagnosis and Treatment of Rheumatoid Arthritis: Current Status and Future Prospects
Fatima Nazish Khan, Mohammad Asim, Mohammad Irfan Qureshi
Studies in computational intelligence (2024), pp. 193-221
Closed Access | Times Cited: 3

Non-Invasive Assessment of Micro- and Macrovascular Function after Initiation of JAK Inhibitors in Patients with Rheumatoid Arthritis
Panagiota Anyfanti, Elena Angeloudi, Athanasia Dara, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 834-834
Open Access | Times Cited: 3

Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review
L Murphy, Mohamad M. Saab, Nicola Cornally, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 7, pp. 2187-2202
Open Access | Times Cited: 3

Autoimmune Diseases and Cardiovascular Risk: Mendelian Randomization Analysis for the Impact of 19 Autoimmune Diseases on 14 Cardiovascular Conditions
Yi Bao, Luo Gu, Jiayi Chen, et al.
Journal of Translational Autoimmunity (2024) Vol. 9, pp. 100259-100259
Open Access | Times Cited: 3

Cardiovascular risk comorbidities in rheumatoid arthritis patients and the use of anti-rheumatic drugs: a cross-sectional real-life study
Gustavo Nogueira Schincariol Vicente, Ivânio Alves Pereira, Gláucio Ricardo Werner de Castro, et al.
Advances in Rheumatology (2021) Vol. 61, Iss. 1
Open Access | Times Cited: 20

Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit
Anne Grete Semb, Silvia Rollefstad, Eirik Ikdahl, et al.
RMD Open (2021) Vol. 7, Iss. 2, pp. e001724-e001724
Open Access | Times Cited: 20

Loganin Inhibits Lipopolysaccharide-Induced Inflammation and Oxidative Response through the Activation of the Nrf2/HO-1 Signaling Pathway in RAW264.7 Macrophages
Cheol Park, Hyesook Lee, Chan‐Young Kwon, et al.
Biological and Pharmaceutical Bulletin (2021) Vol. 44, Iss. 6, pp. 875-883
Open Access | Times Cited: 19

Scroll to top